Akums launches high-strength Paracetamol oral suspension 500mg/5ml
News

Akums launches high-strength Paracetamol oral suspension 500mg/5ml

Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats

  • By IPP Bureau | July 23, 2025

Akums Drugs & Pharmaceuticals Ltd. has announced the launch of Paracetamol Oral Suspension 500mg/5ml in the Indian market. This high-strength, easy-to-administer formulation is designed to improve pain and fever management in adult and geriatric patients.

With this launch, Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats, providing a patient-friendly alternative that promotes better treatment adherence.

Paracetamol 500mg/5ml is among the most concentrated liquid paracetamol formulations available in the Indian market.

By delivering an effective adult dose in just 5ml, it significantly reduces dosing frequency and volume—particularly beneficial in outpatient, hospital, and home care settings across India. It enables rapid symptom relief, especially in cases where IV access is unavailable or oral tablets are ineffective or cause discomfort.

Upcoming E-conference

Other Related stories

Startup

Digitization